8
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Determination of human tumour necrosis factor-α (TNF-α) by time-resolved immunofluorometric assay

&
Pages 475-483 | Received 02 Feb 1994, Accepted 05 May 1994, Published online: 08 Jul 2009

References

  • Carswell E A, Old L J, Kassel R L, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666–70
  • de Groote M A, Martin M A, Densen P, Pfaller M A, Wenzel R P. Plasma tumor necrosis factor levels in patients with presumed sepsis. J Am Med Assoc 1989; 262: 249–51
  • Yocum D E, Esparza L, Dubry S, Benjamin J B, Volz R, Scuderi P. Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cellular Immunol 1989; 122: 131–45
  • Brennan F M, Maini R N, Feldmann M. TNFα- a pivotal role in rheumatoid arthritis?. Br J Rheumatol 1992; 31: 293–8
  • Balkwill F, Osborne R, Burke F, et al. Evidence for tumor necrosis factor/cachectin production in cancer. Lancet 1987; ii: 1229–32
  • Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis toxicity. J Biol Chem 1989; 264: 11974–80
  • Gatanaga T, Hwang C, Kohr W, et al. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafil-trates of human cancer patients. Proc Natl Acad Sci USA 1990; 87: 8781–4
  • Engelmann H, Novick D, Wallach D. Two tumor necrosis factor-binding proteins purified from human urine. J Biol Chem 1990; 265: 1531–6
  • Lantz M, Gullberg U, Nilsson E, Olsson I. Characterization in vitro of a human tumor necrosis factor-binding protein. J Clin Invest 1990; 86: 1396–402
  • Nophar Y, Kemper O, Brakebusch C, et al. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 1990; 9: 3269–78
  • Brockhaus M, Schoenfeld H-J, Schlaeger E-J, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 3127–31
  • Kohno T, Brewer M T, Baker S L, et al. A second tumor necrosis factor receptor gene product can shed a naturally occuring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 1990; 87: 8331–5
  • Schall T J, Lewis M, Koller K J, et al. Molecular cloning and expression of a receptor for tumor necrosis factor. Cell 1990; 61: 361–70
  • Kramer S M, Carver M E. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol Methods 1986; 93: 201–6
  • Meager A, Leung H, Woolley J. Assays for tumor necrosis factor and related cytokines. J Immunol Methods 1989; 116: 1–17
  • Teppo A-M, Maury C PJ. Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 1987; 33: 2024–7
  • Engelberts I, Möller A, Schoen G JM, van der Linden C J, Buurman W A. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine and Cytokine Res 1991; 10: 69–76
  • Liabakk N-B, Nustad K, Espevik T. A rapid and sensitive immunoassay for tumor necrosis factor using magnetic monodisperse polymer particles. J Immunol Methods 1990; 134: 253–9
  • Lamb W R, Pumphrey R SH, Brenchley P EC. A peroxidase-linked enzyme immunoassay for tumour necrosis factor α utilising alternative colorimetric or chemilumimetric substrates. J Immunol Methods 1992; 155: 215–23
  • Ogata A, Tagoh H, Lee T, et al. A new highly sensitive immunoassay for cytokines by dissociation-enhanced lanthanide fiuoroimmunoassay (DEL-FIA). J Immunol Methods 1992; 148: 15–22
  • Jackson T M, Ekins R P. Theoretical limitations on immunoassay sensitivity. Current practice and potential advantages of fluorescent Eu3+ chelates as non-radioisotopic tracers. J Immunol Methods 1986; 87: 13–20
  • Lövgren T, Hemmilä I, Pettersson K, Eskola J U, Bertoft E. Determination of hormones by time-resolved fluoroimmunoassay. Talanta 1984; 31: 909–16
  • Wide L, Bennich H, Johansson S GO. Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 1967; ii: 1105–7
  • Miles L EM, Hales C N. Labelled antibodies and immunological assay systems. Nature 1968; 219: 186–9
  • Christopoulos T K, Lianidou E S, Diamandis E P. Ultrasensitive time-resolved fluorescence method for α-fetoprotein. Clin Chem 1990; 36: 1497–502
  • Diamandis E P. Multiple labeling and time-resolvable fluorophores. Clin Chem 1991; 37: 1486–91
  • Knopf H-P, Papoian R. Preparation of europium-streptavidin in a time-resolved fluoroimmunoassay for interleukin-3. J Immunol Methods 1991; 138: 233–6
  • Vilja P. One- and two-step non-competitive avidin-biotin immunoassays for monomeric and hetero-dimeric antigen. J Immunol Methods 1991; 136: 77–84
  • Suonpaa M, Markela E, Stahlberg T, Hemmilä I. Europium-labelled streptavidin as a highly sensitive universal label. Indirect time-resolved immuno-fluorometry of FSH and TSH. J Immunol Methods 1992; 149: 247–53
  • Osman S, Turpeinen U, Itkonen O, Stenman U-H. Optimization of a time-resolved immunofluoro-metric assay for tumour-associated trypsin inhibitor (TATI) using the streptavidin-biotin system. J Immunol Methods 1993; 161: 97–106
  • Turpeinen U, Stenman U-H. Determination of fetal hemoglobin by time-resolved immunofluoro-metric assay. Clin Chem 1992; 38: 2013–18
  • Alfthan H, Stenman U-H. Purification of labelled antibodies by hydrophobic interaction chromatography. J Chromatogr 1989; 470: 385–9
  • Bland J M, Altman D G. Statistical methods assessing agreement between two methods of clinical measurement. Lancet 1986; I: 307–10
  • Bayer E A, Wilchek M. Protein biotinylation. Methods Enzymol 1990; 184: 138–60
  • Diamandis E P, Christopoulos T K. The biotin-(strept)avidin system: Principles and applications in biotechnology. Clin Chem 1991; 37: 625–36
  • Lepage N, Roberts K D, Langlais J. Interference of lysophosphatidylcholine in hormone radioimmunoassays. Clin Chem 1993; 39: 865–9
  • Stenman U-H, Alfthan H, Turpeinen U. Method dependence of interpretation of immunoassay results. Scand J Clin Lab Invest 1991; 51(suppl 205)86–94
  • Michie H R, Kirk R M, Spriggs D R, et al. Detection of circulating tumor necrosis factor after endotoxin administration. New Engl J Med 1988; 318: 1481–6
  • Kalinkovich A, Engelmann H, Harpaz N, et al. Elevated serum levels of soluble tumor necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol 1992; 89: 351–5
  • Lauria F, Raspadori D, Benfenati D, Rondelli D, Pallotti A, Tura S. Biological markers and minimal residual disease in hairy cell leukemia. Leukemia 1992; 6(suppl. 4)149–51
  • Englelberts I, Stephens S, Francot G JM, van der Linden C J, Buurman W A. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 1991; 338: 515–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.